Penn researchers identify cancer cell defect driving resistance to CAR T cell therapy

(University of Pennsylvania School of Medicine) Some cancer cells refuse to die, even in the face of powerful cellular immunotherapies like CAR T cell therapy, and new research is shedding light on why.